Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
—
—
—
—
—
—
1 Year
Score—
Net Growth—
Net Trend—
Net Income Consistency—
Rev Growth—
Rev Trend—
Revenue Consistency—
5 Years
—
—
50%
—
—
Never
—
5 Years
Score—
Net Growth—
Net Trend50%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Universe Pharmaceuticals Inc fundamental performance
Across Universe Pharmaceuticals Inc's full reported history, from 2021 to 2025, revenue declined from $ 47M to $ 17M and net income went from $ 11M to -$ 3M. Revenue increased in 0% of the years measured; net income in 50%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 6.06 | — |
1 Year2025-08-12 | $ 3.41 | 77.71% |
5 Years2021-08-12 | $ 1.51K | -99.60% |
All Time2021-03-23 | $ 2.85K | -99.79% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-03-23 |
|---|---|---|---|---|
| Price | $ 6.06 | $ 3.41 | $ 1.51K | $ 2.85K |
| Return | — | 77.71% | -99.60% | -99.79% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 33M | ||
| 2025 | $ 17M | -$ 3M | $ 33M |
| 2024 | $ 23M | -$ 8M | |
| 2023 | $ 32M | -$ 6M | $ 18M |
| 2022 | $ 40M | -$ 8M | $ 18M |
| IPO2021 | $ 47M | $ 11M | $ 21M |
Explore beyond UPC
You're looking at Universe Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
